By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


CSL Limited 

45 Poplar Road

Parkville  Victoria  3052  Australia
Phone: 61-3-9389-1911 Fax: 61-3-9389-1434



Company News
CSL Limited (CMXHF.PK) To Acquire Majority Stake In Chinese Plasma Fractionator Wuhan Zhong Yuan Rui De Biologicals Products 6/13/2017 7:21:24 AM
General Counsel Greg Boss Of Global Biotherapeutics Leader CSL Limited (CMXHF.PK) Receives Career Honor From Directors Roundtable 9/16/2016 8:36:34 AM
CSL Limited (CMXHF.PK) CEO Says Corporate Responsibility And Sustainability Are All About Continuous Improvement 12/18/2015 3:24:22 PM
CSL Limited (CMXHF.PK) Release: CSL Brands World's No. 2 Influenza Vaccine Provider As Seqirus 11/9/2015 11:13:00 AM
CSL Limited (CMXHF.PK) Release: FDA Advisory Panel Recommends Licensure of NVS Influenza Candidate Vaccine for Protection Against Seasonal Influenza in the Elderly 9/16/2015 11:04:33 AM
Biocryst Pharmaceuticals (BCRX) Licenses Worldwide Rights To Commercialize RAPIVAB Influenza Treatment To CSL Limited (CMXHF.PK) 6/17/2015 7:04:44 AM
CSL Limited (CMXHF.PK) Launches AEGIS-I, A Phase 2b Clinical Study Of CSL112, A Novel Apolipoprotein A-I Infusion Therapy Designed To Rapidly Remove Cholesterol From Arteries And Stabilize Plaque 11/12/2014 7:14:14 AM
Novartis AG (NVS) Sells Flu Vaccine Business For $275 Million To CSL Limited (CMXHF.PK) 10/27/2014 5:50:08 AM
Apathy Sends Biotech Jobs Offshore, Says CSL Limited (CMXHF.PK) 8/18/2014 8:03:22 AM
ASLAN Pharmaceuticals Pte Ltd In-Licenses Novel Asthma Therapy From CSL Limited (CMXHF.PK) 5/13/2014 8:21:13 AM